1. LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma
   Lei Li et al, 2024, Aging CrossRef
2. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis
   Takeo Toshima et al, 2015, Journal of Gastroenterology CrossRef
3. M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection
   Bin Wei et al, 2018, Journal of Clinical Laboratory Analysis CrossRef
4. MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC
   Peng Hao et al, 2018, Oncology Letters CrossRef
5. 90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro
   Yu Zeng et al, 2021, Aging CrossRef
6. Recent Advances of Proteomics in Management of Acute Kidney Injury
   Ilinka Pejchinovski et al, 2023, Diagnostics CrossRef
7. Differences in urinary proteins related to surgical margin status after radical prostatectomy
   ZBYNEK HEGER et al, 2015, Oncology Reports CrossRef
8. Tissue proteomics studies in the investigation of prostate cancer
   Anna Mantsiou et al, 2018, Expert Review of Proteomics CrossRef
9. Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection
   Hidenori Toyoda et al, 2022, European Radiology CrossRef
10. Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in chronic hepatitis C patients
    Ching‐I Huang et al, 2017, The Kaohsiung Journal of Medical Sciences CrossRef
11. Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
    Emily Capone et al, 2021, Journal of Translational Medicine CrossRef
12. Serum WFA+‐M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection
    Hidenori Toyoda et al, 2016, Liver International CrossRef
13. Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C
    Seiichi Tawara et al, 2016, PLOS ONE CrossRef
14. Elevated plasma levels of Mac-2 binding protein predict poor cardiovascular outcomes in patients with acute coronary syndrome
    Hao Xie et al, 2017, Coronary Artery Disease CrossRef
15. Glycoconjugates from extracellular vesicles: Structures, functions and emerging potential as cancer biomarkers
    Julia Costa, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
16. Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review
    Mattia Bellan et al, 2018, Journal of Clinical and Translational Hepatology CrossRef
17. Circular RNA circABCC4 as the ceRNA of miR‐1182 facilitates prostate cancer progression by promoting FOXP4 expression
    Changkun Huang et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
18. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response
    Ryu Sasaki et al, 2015, PLOS ONE CrossRef
19. A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma
    Li Guo et al, 2022, Computational and Structural Biotechnology Journal CrossRef
20. Are Serum Mac 2-Binding Protein Levels Elevated in Esophageal Cancer? A Control Study of Esophageal Squamous Cell Carcinoma Patients
    Ufuk Cobanoglu et al, 2018, Disease Markers CrossRef
21. Surface-enhanced Raman scattering (SERS)–based immunosystem for ultrasensitive detection of the 90K biomarker
    Valentina Gallo et al, 2020, Analytical and Bioanalytical Chemistry CrossRef
22. Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy
    null null et al, 2016, Hepatology International CrossRef